- ‘Designer Drug’ Shows Early Neuroprotective Signal in Acute Ischemic Stroke Medscape
- Silver Creek’s stroke hopeful yields mixed results in Phase II trial Clinical Trials Arena
- Silver Creek Pharmaceuticals Receives FDA Fast Track Designation for Scp776 in Acute Ischemic Stroke GlobeNewswire
- Silver Creek Pharmaceuticals Announces Positive Phase 2 Results for Scp776 in Acute Ischemic Stroke Yahoo Finance